Stock Analiz

IQV vs INCY stock comparison

Iqvia vs. Incyte · data as of November 13, 2026

Iqvia (IQV) has a market value of about $43.7B, Incyte (INCY) about $24.7B. Over their latest twelve months Iqvia had revenue of $17.3B and Incyte $6.0B.

On our five checks Incyte scores higher: 2.8 out of 5 (average) against 1.6 (weak).

By area, the stronger company is Iqvia on value; Incyte on future growth; Incyte on financial health; Iqvia on shareholder returns.

Iqvia is cheaper on earnings (P/E 32.3 vs. 61.7), while Incyte grew revenue faster over five years (14.0% vs. 7.5% a year).

Iqvia leads on 12 of the compared lines and Incyte on 7.

Side by side

IQVINCY
Size and price
Market cap$43.7B$24.7B
Share price$265.12$120.97
Score
Overall score (of 5)1.62.8
Value10
Future growth04
Track record33
Financial health15
Shareholder returns32
Valuation
P/E (TTM)32.361.7
Forward P/E19.215.1
Price / free cash flow21.036.3
Price / sales2.54.1
EV / EBITDA16.829.5
PEG0.80—
DCF value vs. price−24%−48%
Business
Revenue$17.3B$6.0B
Net income$1.4B$403M
Free cash flow$2.1B$680M
Net margin8.1%6.7%
Gross margin (5-yr avg.)—93.5%
ROIC (5-yr avg.)8.0%10.6%
Growth
Revenue growth (1 yr)5.9%21.2%
Revenue growth (5 yrs, per year)7.5%14.0%
EPS growth (5 yrs, per year)40.5%—
Balance sheet and payouts
Net cash (cash minus debt)-$14.0B—
Dividend yieldNoneNone
Shareholder yield2.9%0.0%
Analysts
Upside to average target+18%+9%
Consensus ratingStrong buyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: IQV TTM to September 30, 2026, INCY TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Iqvia or Incyte?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Incyte scores 2.8 out of 5 and Iqvia 1.6; the table shows where each one is stronger.

Is Iqvia cheaper than Incyte?

On trailing earnings, Iqvia trades at a P/E of 32.3 and Incyte at 61.7, so Iqvia is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Iqvia or Incyte?

Over five years Incyte grew revenue about 14.0% a year and Iqvia about 7.5% a year.

Full Iqvia analysis → Full Incyte analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.